Skip to main content

Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis.

Publication ,  Conference
Bickel, KE; Niland, JC; Mamet, R; Zornosa, CC; Ettinger, DS; Pisters, K; Otterson, GA; Koczywas, M; Reid, ME; Rabin, MS; D'Amico, TA; Earle, C ...
Published in: Journal of Clinical Oncology
May 20, 2011

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2011

Volume

29

Issue

15_suppl

Start / End Page

7537 / 7537

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bickel, K. E., Niland, J. C., Mamet, R., Zornosa, C. C., Ettinger, D. S., Pisters, K., … Kalemkerian, G. P. (2011). Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis. In Journal of Clinical Oncology (Vol. 29, pp. 7537–7537). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2011.29.15_suppl.7537
Bickel, K. E., J. C. Niland, R. Mamet, C. C. Zornosa, D. S. Ettinger, K. Pisters, G. A. Otterson, et al. “Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis.” In Journal of Clinical Oncology, 29:7537–7537. American Society of Clinical Oncology (ASCO), 2011. https://doi.org/10.1200/jco.2011.29.15_suppl.7537.
Bickel KE, Niland JC, Mamet R, Zornosa CC, Ettinger DS, Pisters K, et al. Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. 7537–7537.
Bickel, K. E., et al. “Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis.Journal of Clinical Oncology, vol. 29, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2011, pp. 7537–7537. Crossref, doi:10.1200/jco.2011.29.15_suppl.7537.
Bickel KE, Niland JC, Mamet R, Zornosa CC, Ettinger DS, Pisters K, Otterson GA, Koczywas M, Reid ME, Rabin MS, D’Amico TA, Earle C, Pini TM, Kalemkerian GP. Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. 7537–7537.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2011

Volume

29

Issue

15_suppl

Start / End Page

7537 / 7537

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences